Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Sun Pharma initiated recall of several drugs manufactured at Dadra site (India) for cGMP deviation – microbial contamination in stagnant water in the duct of manufacturing equipment. The drugs recalled include OSD Drugs Cinacalcet tablets, Febuxostat tablets, Lurasidone tablets, Mesalamine Delayed-Release Tablets, Niacin Extended release tablets, Zolpidem Tartrate Extended-Release Tablets, Fexofenadine Hydrochloride Tablets. The Class II recall was initiated by Sunpharma on Jan 18, 2024.

Enforcement Report (Recall)

Leave a Comment